RALEIGH, N.C., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Syneos Health TM (Nasdaq: SYNH ), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced that Chief Financial Officer Jason Meggs is scheduled to present at the 2018 Baird Global Healthcare Conference in New York, NY, on Thursday, September 6, 2018, at 12:15 p.m. ET.

A live webcast and archived audio replay of the event, as well as links to the presentation materials, will be available on the Company’s Investor Relations website at investor.syneoshealth.com .

About Syneos Health Syneos Health (Nasdaq: SYNH ) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 22,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life ® visit syneoshealth.com . Contacts

Investor Relations: Ronnie Speight Vice President, Investor Relations +1 919 745 2745 Investor.Relations@syneoshealth.com

Press/Media: Danielle DeForge Executive Director, External Communications +1 202 210 5992 danielle.deforge@syneoshealth.com